The Lundquist Institiute (formerly LA BioMed)

5:15 PM - 5:30 PM, Monday, June 3, 2019 ・ Theater 3
The Lundqusit Institute (formerly LA BioMed) is an independent non-profit research institute located in the South Bay region of Los Angeles on a 72-acre campus shared with the Harbor-UCLA Medical Center. The Lundqusit has over 100 principal investigators and 400 researchers in total, a translational focus, and its innovations have led to 600 issued and pending patents and thirteen start-up companies. We obtain ~$70,000,000 each year in NIH grant funding and sponsored research and our technologies have helped to generate numerous global breakthroughs: • The cholesterol test • The US paramedic model • FDA 510k-cleared revolutionary heart monitoring medical device by QT Medical • FDA-approved drug Aldurazyme® for Mucopolysaccharidosis BioMarin/Sanofi) • FDA-approved drug (with UCLA) to treat submental fullness (Kybella®, Allergan) • FDA-approved drug for the treatment of pain associated with sickle-cell anemia (Endari®, Emmaus)
Not Provided.
Not Provided.
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Not Provided.
Development Phase of Primary Product:
Not Provided.
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided.
Vice President of Business Development & Tech Transfer
The Lundquist Institute (formerly LA BioMed)